Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-31-3p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 198, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
SLC26A3 hsa-miR-31-3p low: 3 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 3 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Arivarasu N. Anbazhagan et al. 2014 WB qP Kidney CACO2 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
UNKNOWN qPCR NEGATIVE INDIRECT TarBase 7.0
Arivarasu N. Anbazhagan et al. 2014 RP Kidney CACO2 CACO2 N/A
Location Method Result Regulation Validation Type Source
chr7:107765483-107765830 Luciferase Reporter Assay NEGATIVE DIRECT TarBase 7.0
RICTOR hsa-miR-31-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:38941048-38941072 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Helwak Aleksandra et al. 2013 IP Kidney FLPIN_TREX_293 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:38942322-38942371 CLASH POSITIVE DIRECT TarBase 7.0
INHBA hsa-miR-31-3p low: 0 high: 1 1 2 2 0.525
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 IP Kidney FLPIN_TREX_293 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:41685462-41685509 CLASH POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
RAN hsa-miR-31-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 IP Kidney FLPIN_TREX_293 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:130874652-130874709 CLASH POSITIVE DIRECT TarBase 7.0
RAN hsa-miR-31-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 IP Kidney FLPIN_TREX_293 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:130874652-130874709 CLASH POSITIVE DIRECT TarBase 7.0
E2F3 hsa-miR-31-3p low: 0 high: 3 2 2 2 0.896
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr6:20493124-20493146 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:20493124-20493146 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:20493124-20493146 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF1 hsa-miR-31-3p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:41691499-41691525 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:41691499-41691525 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:41691499-41691525 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZBTB18 hsa-miR-31-3p low: 0 high: 3 1 1 1 0.687
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:244055485-244055513 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:244055485-244055513 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:244055485-244055513 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WEE1 hsa-miR-31-3p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:9589517-9589536 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:9589517-9589536 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:9589076-9589100 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AFF4 hsa-miR-31-3p low: 0 high: 2 2 2 2 0.469
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr5:132937192-132937218 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:132934452-132934474 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WDR48 hsa-miR-31-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr3:39074769-39074791 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:39074769-39074791 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NCL hsa-miR-31-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:231456680-231456700 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:231456680-231456700 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TRIM41 hsa-miR-31-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr5:181233678-181233699 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:181233678-181233699 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FAM160B1 hsa-miR-31-3p low: 0 high: 2 1 1 1 0.612
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr10:114864049-114864075 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr10:114864049-114864075 HITS-CLIP POSITIVE DIRECT TarBase 7.0
STARD4 hsa-miR-31-3p low: 0 high: 2 2 2 2 0.667
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:111499794-111499801 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr5:111497709-111497716 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FTH1 hsa-miR-31-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:61967536-61967555 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr11:61964703-61964723 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KLHL15 hsa-miR-31-3p low: 0 high: 2 2 2 2 0.492
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chrX:23985336-23985360 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:23985336-23985360 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RDX hsa-miR-31-3p low: 0 high: 2 1 1 1 0.597
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:110229797-110229815 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:110229797-110229815 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBE2Z hsa-miR-31-3p low: 0 high: 2 1 1 1 0.602
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:48928888-48928911 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:48928874-48928897 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNKS2 hsa-miR-31-3p low: 0 high: 1 2 2 2 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:91865002-91865025 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase